The structures reveal how oligoclonal TCRs 12-6, 38-10, and 1a2 discriminate between wild-type and mutated p53, and demonstrate that there are multiple distinct solutions to recognizing the p53R175H neoepitope with sufficient affinity to mediate tumor cell killing. Here, TP53 is linked to neoplasm.